NCT05124470

Brief Summary

ARCoS is a pilot study evaluating the feasibility and preliminary effects of a method of cognitive remediation by a Rhythmic, Vocal and Embodied Musical Learning for a population of stabilized schizophrenic patients. 20 stabilized schizophrenics patients will participate in the study for 9 months, i) 6 months of Musical learning (24 sessions over the 6 months) ; ii) and 3 months of follow-up post cognitive remediation. Assessments of attention deficits, inhibitory abilities, negative symptoms and anxiety, will carried out at baseline (V1, M0), third month (M3), sixth month (M6) after the start of the intervention and third months after the end of the intervention (M9). The primary endpoint will be the proportion of patients who have attended at least 80% of the musical training sessions over the 6 months (participation in at least 19/24 sessions).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable schizophrenia

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable schizophrenia

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 18, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2022

Completed
Last Updated

March 31, 2023

Status Verified

March 1, 2023

Enrollment Period

11 months

First QC Date

October 27, 2021

Last Update Submit

March 29, 2023

Conditions

Keywords

Psychiatric RehabilitationMusic TherapyCognitive Remediation

Outcome Measures

Primary Outcomes (1)

  • proportion of patients who have attended at least 80% of the musical training sessions over the 6 months

    The primary outcomes will be the proportion of patients who have attended at least 80% of the musical training sessions over the 6 months (participation in at least 19/24 sessions).

    6 months

Secondary Outcomes (10)

  • list of factors of no adherence to musical learning

    6 months

  • Reduce of attention deficits at 6 month

    6 months

  • Reduce of attention deficits at 9 month

    9 months

  • Improving inhibitory abilities at 6 month

    6 months

  • Improving inhibitory abilities at 9 month

    9 months

  • +5 more secondary outcomes

Study Arms (1)

musical training sessions

EXPERIMENTAL

24 musical training sessions over the 6 months + 3 months of follow-up post cognitive remediation.

Other: cognitive remediation by musical training sessions

Interventions

The musical learning method "Diapason \& Metronome" is unprecedented. It was specially created by Florent Cholat. It aims an apprenticeship of a musical practice adapted to subjects with schizophrenia. The method does not require the handling of a musical instrument; it is based on the voice and the body. It is built on the three essential dimensions of music, which are rhythm, single sound and harmony. "Rhythm" concerns the division and management of time. The "single sound" allows work on the representation of a sound object as a singularity. "Harmony" allows you to work on the positioning of a sound in the globality of the chord to which it belongs and in the collective polyphony exercises.

musical training sessions

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Established schizophrenia or with schizoaffective disorder as per Diagnostic and Statistical Manual (DSM 5)
  • Clinically stable (with no full-time hospitalization within the last 6 months)
  • Regular follow-up (followed in a day Hospital of Psychiatric)
  • Patient must be on stable background antipsychotic treatment (with no modification within the last 6 month)
  • \. Male or female patients who are 18-60 years of age 5. Signed and dated written consent 6. Patient having a health Insurance coverage

You may not qualify if:

  • Patient with moderate to severe intellectual disabilities (clinical criteria)
  • Addictive comorbidity (excluding tobacco and behavioral addictions)
  • Previous neurologic pathology with cognitive impact
  • Patient who are following a cognitive rehabilitation program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CH Marchant

Toulouse, France

Location

CHU Toulouse

Toulouse, France

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • TUDI L GOZE, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2021

First Posted

November 18, 2021

Study Start

December 1, 2021

Primary Completion

October 21, 2022

Study Completion

October 21, 2022

Last Updated

March 31, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations